MSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies - Galon, J.; Mlecnik, B.; Hermitte, F.; Marliot, F.; Bifulco, C.; Lugli, A.; Nagtegaal, I. D.; Hartmann, Arndt; Van Den Eynde, M.; Roehrl, M.; Ohashi, P.; Zavadova, E.; et al. (ANNALS OF ONCOLOGY, 2018)
CRIS-Team WoS Importer:2019-03-06